Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 Jul 7.

Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):665–669. doi: 10.1097/QAI.0000000000002488

Figure 1. — Baseline (BL) to Week (Wk) 12 percent changes in the gut mucosal frequencies of (A) CD4⁺ T cells, (B) CD8⁺ T cells, (C) regulatory T cells (Treg; CD4⁺ CD25^HI FOXP3⁺), and (D) Th17 cells (CD4⁺ IL17A⁺ T cells following stimulation). Graphs show median and interquartile range. *Outlier values in the dipyridamole arm (102.5% change in mucosal CD8⁺ T cell and 4255% change in gut Th17 cells) and an **outlier value in the placebo arm (1346.8% change in gut Treg) was excluded in the graphs but included in the statistical analyses.

Figure 1. — Baseline (BL) to Week (Wk) 12 percent changes in the gut mucosal frequencies of (A) CD4⁺ T cells, (B) CD8⁺ T cells, (C) regulatory T cells (Treg; CD4⁺ CD25^HI FOXP3⁺), and (D) Th17 cells (CD4⁺ IL17A⁺ T cells following stimulation). Graphs show median and interquartile range. *Outlier values in the dipyridamole arm (102.5% change in mucosal CD8⁺ T cell and 4255% change in gut Th17 cells) and an **outlier value in the placebo arm (1346.8% change in gut Treg) was excluded in the graphs but included in the statistical analyses.